Logo Image

Shorts

Solving the Mental Health Crisis in Cancer Care
0:47
Solving the Mental Health Crisis in Cancer Care
9 months ago
by
Nina Balanchivadze, MD, FACP(+1 more)
ADCs & Bispecifics: The Future of B-Cell Lymphoma
0:27
ADCs & Bispecifics: The Future of B-Cell Lymphoma
10 months ago
by
Matthew J. Matasar, MD
Moving Bispecifics and CAR T Into the Community
0:43
Moving Bispecifics and CAR T Into the Community
10 months ago
by
James Essell, MD
Why Real-World Community Oncology Data is Vital for Addressing Disparities
0:43
Why Real-World Community Oncology Data is Vital for Addressing Disparities
10 months ago
by
Ira Zackon, MD
Improving Patient Outcomes With Remote Therapeutic Monitoring
0:38
Improving Patient Outcomes With Remote Therapeutic Monitoring
10 months ago
by
James Essell, MD
How New Treatment Timing Allows Fast Outpatient Care in Myeloma
0:41
How New Treatment Timing Allows Fast Outpatient Care in Myeloma
10 months ago
by
Krina K. Patel, MD, MSc
Challenging the "Perfect Match" Assumption for Transplants
0:27
Challenging the "Perfect Match" Assumption for Transplants
10 months ago
by
Heather Stefanski, MD, PhD
The Truth About Anemia Levels and Lifespan in MDS
1:03
The Truth About Anemia Levels and Lifespan in MDS
10 months ago
by
Ira Zackon, MD
Dr Voorhees: Identifying Ideal Candidates for SC Daratumumab
1:00
Dr Voorhees: Identifying Ideal Candidates for SC Daratumumab
a year ago
by
Peter Voorhees, MD
The Return to In-Person Oncology Collaboration
0:30
The Return to In-Person Oncology Collaboration
a year ago
by
Robert L. Ferris, MD, PhD
The Future is Still Bright for Cancer Research
0:41
The Future is Still Bright for Cancer Research
a year ago
by
Robert L. Ferris, MD, PhD
Improving Progress in Cancer Research
0:42
Improving Progress in Cancer Research
a year ago
by
Robert L. Ferris, MD, PhD
Managing Infection with BCMA-Targeting Bispecifics
0:45
Managing Infection with BCMA-Targeting Bispecifics
a year ago
by
Marc Raab, MD
Why Use Frontline Bispecifics in Myeloma
0:33
Why Use Frontline Bispecifics in Myeloma
a year ago
by
Marc Raab, MD
Why "One Size" Policies Fail Rural Communities
0:33
Why "One Size" Policies Fail Rural Communities
a year ago
by
Enrique Soto Pérez de Celis, MD, MSc
Shifting Health Care Culture Requires Everyone Learning Together
0:35
Shifting Health Care Culture Requires Everyone Learning Together
a year ago
by
Cheyenne Corbett
Why Cancer Care Needs a "Both/And" Approach
0:35
Why Cancer Care Needs a "Both/And" Approach
a year ago
by
Cheyenne Corbett
Ego vs the Patient: The Hardest Medical Decision
0:32
Ego vs the Patient: The Hardest Medical Decision
a year ago
by
Cheyenne Corbett
Why Oncology is a "Black Box" for Most Primary Care Providers
0:26
Why Oncology is a "Black Box" for Most Primary Care Providers
a year ago
by
Cheyenne Corbett
The Silent Crisis in Rural Health Care
0:37
The Silent Crisis in Rural Health Care
a year ago
by
Enrique Soto Pérez de Celis, MD, MSc
Can Quality Cancer Care Reach Rural America?
0:38
Can Quality Cancer Care Reach Rural America?
a year ago
by
Enrique Soto Pérez de Celis, MD, MSc
The Biggest Challenges Facing Rural Cancer Care
0:41
The Biggest Challenges Facing Rural Cancer Care
a year ago
by
Enrique Soto Pérez de Celis, MD, MSc
The Power of Perseverance: Finding Strength in Shared Journeys
1:01
The Power of Perseverance: Finding Strength in Shared Journeys
a year ago
by
Jered Haddad
Empowering Conversations: A Guide for Supporting New Diagnoses
0:38
Empowering Conversations: A Guide for Supporting New Diagnoses
a year ago
by
Jered Haddad
The Best Advice From an Oncologist to a Patient
0:48
The Best Advice From an Oncologist to a Patient
a year ago
by
Michael Cole
Unlocking New Possibilities in Bladder Cancer Treatment
0:41
Unlocking New Possibilities in Bladder Cancer Treatment
a year ago
by
Andrea Necchi, MD
Dr Patel: Considerations for Adjuvant Cemiplimab in CSCC
1:23
Dr Patel: Considerations for Adjuvant Cemiplimab in CSCC
a year ago
by
Vishal A. Patel, MD
Trial Opens Up More Avenues for Treatment in Patients with Bladder Cancer
1:10
Trial Opens Up More Avenues for Treatment in Patients with Bladder Cancer
a year ago
by
Christof Vulsteke, MD, PhD
A 13-Year-Old Drug’s Persisting Power in Prostate Cancer
0:41
A 13-Year-Old Drug’s Persisting Power in Prostate Cancer
a year ago
by
Stephen J. Freedland, MD
Clinical Trial Achieves 60% Reduction in the Risk of Tumor Recurrence
1:16
Clinical Trial Achieves 60% Reduction in the Risk of Tumor Recurrence
a year ago
by
Christof Vulsteke, MD, PhD